SA Pathology

Site

Frome Road Laboratory

Accreditation No.

2348

Site No.

2341

Date of Accreditation

08 Apr 1988

Address

7 Frome Road
Adelaide, SA 5000
Australia

sapathology.sa.gov.au

Contact

Mr Jason Graefling P: +61 (08) 82223137

Availability

Services available to external clients

Supervision

GY (General)

Scope of Accreditation

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions Cervical tissue Cytological examination; Review and reporting of cervical cytological material
Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions Vaginal tissue Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy Other body fluids; Sputum; Urine; Washings or brushings from other sites Cytological examination; Review and reporting of cytology samples
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears Cytological examination; Review and reporting of cytology samples
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy Fine needle aspirates (FNA) Cytological examination; Review and reporting of fine needle aspiration samples
Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program Liquid based cytology specimens from cervix Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material
Anatomical pathology - Tissue pathology - Examination of biopsy material Formalin fixed tissue; Fresh tissue; Gluteraldehyde fixed tissueNerve only Review and reporting of biopsy material to identify or exclude morphological abnormalities
Formalin fixed tissue; Fresh tissueMuscle only Review and reporting of biopsy material to identify or exclude morphological abnormalities
Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy Gluteraldehyde tissue Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities
Anatomical pathology - Tissue pathology - Immunohistochemical investigation Frozen sections of fresh tissueMuscle only Detection of antigenic targets - Various
Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus Semen Presence of spermatozoa

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProduct received from Royal Adelaide Hospital Haematology Day Centre and WCH Apheresis Services Bone marrow; Haemopoietic progenitor cells Processing; Storage (includes freezing/thawing)
Haemopoietic progenitor cells Enumeration of CD34+ cells

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals Plasma; Serum Fentanyl; Methadone; Morphine; Oxycodone
Chemical pathology - Biogenic amines Plasma Metanephrine
Urine 4-Hydroxy-3-methoxymethamphetamine (HMMA); 5-Hydroxyindoleacetic acid (5-HIAA); Homovanillic acid (HVA)
Catecholamines; Metanephrine
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring Plasma; Serum Amiodarone; Aripiprazole; Flecainide; Lamotrigine; Levetiracetam; Mycophenolate; Paliperidone; Perhexiline; Risperidone
Clozapine; Olanzapine; Quetiapine
5-Flucytosine; 6-Mercaptopurine; 6-Thioguanine

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Molecular genetics - Bioinformatic analysis DNA sequences Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation
Molecular genetics - DNA sequencing Blood DNA sequence analysis

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Cytogenetics - Detection of defined, unbalanced chromosomal abnormalities by in-situ hybridisation techniques Blood; Bone marrow; Tissues Cytogenetic analysis and reporting
Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalities Blood; Bone marrow; Tissues Cytogenetic analysis and reporting
Cytogenetic analysis and reporting

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Whole exome sequencing studies for inherited (germline) DNA/RNA changes Blood Acute myeloid leukaemia RUNX1; Bannayan-Riley-Ruvalcaba syndrome; Cowden syndrome (multiple hamartoma syndrome); Emberger syndrome; Familial adenomatous polyposis; Fanconi anaemia; Gastrointestinal stroma tumour; Hemangioblastoma; Hereditary diffuse gastric cancer; Immunodeficiency; Juvenile polyposis; Lynch syndrome; Macrocephaly PTEN gene mutation; Maturity onset diabetes of the young (MODY); Multiple endocrine neoplasia type 1 (MEN1); Multiple endocrine neoplasia type 2 (MEN2); Neurofibromatosis; PTEN hamartoma tumour syndrome (PHTS); Paragangliomas; Phaeochromocytoma; Primary cilary dyskenesis; Renal clear cell carcinoma; Retinoblastoma; Schwannomatosis; Von Hippel Lindau disease
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Amniotic fluid; Blood; Buccal swabs; Chorionic villus Acute myeloid leukaemia RUNX1; Bannayan-Riley-Ruvalcaba syndrome; Cowden syndrome (multiple hamartoma syndrome); Emberger syndrome; Familial adenomatous polyposis; Gastrointestinal stroma tumour; Hemangioblastoma; Hereditary diffuse gastric cancer; Lynch syndrome; Macrocephaly PTEN gene mutation; Multiple endocrine neoplasia type 1 (MEN1); Multiple endocrine neoplasia type 2 (MEN2); Neurofibromatosis; PTEN hamartoma tumour syndrome (PHTS); Paragangliomas; Phaeochromocytoma; Renal clear cell carcinoma; Retinoblastoma; Schwannomatosis; Von Hippel Lindau disease

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation Formalin fixed paraffin embedded tissue sections Detection of antigenic targets - Various
Chemical pathology - Further investigation of renal and/or hepatic function Plasma; Serum Tryptase
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies Plasma; Serum C1 esterase inhibitor
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) Blood HLA-DR1; HLA-DR4
Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Fresh tissue; Lavage; Serous fluid CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD16; CD19; CD197; CD1a; CD2; CD20; CD21; CD22; CD23; CD235a; CD24; CD25; CD27; CD28; CD3; CD30; CD33; CD34; CD38; CD4; CD41; CD45; CD45RA; CD45RO; CD5; CD56; CD57; CD58; CD61; CD64; CD65; CD7; CD71; CD8; CD81; FMC7; HLA-DR antigen; Immunoglobulin G (IgG); Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; T-cell receptor aβ (TCRab); T-cell receptor β (TCRb); T-cell receptor γδ (TCRgd)
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies Cerebrospinal fluid (CSF); Serum Anti-AMPA-1; Anti-AMPA-2; Anti-CV2; Anti-Hu; Anti-Ma-2; Anti-N-methyl-D-aspartate receptor antibodies (NMDA); Anti-Ri; Anti-SOX1; Anti-Tr/DNER; Anti-Yo; Anti-Zic4; Anti-amphiphysin; Anti-aquaporin 4 antibodies (AQP4); Anti-contactin associated protein-like 2 (CASPR-2_; Anti-gamma aminobutyric acid (GABA); Anti-glutamic acid decarboxylase 65 (GAD65); Anti-leucine rich glioma inactivated protein 1 antibodies (LGI 1); Anti-neuronal antibodies; Anti-recoverin; Anti-titin
Plasma; Serum Anti-Purkinje cell antibodies (PCA2)
Paraneoplastic neurologic syndrome antibodies
Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-smooth muscle antibodies (SMA)
Anti-actin antibodies (AAA); Anti-phospholipase A2 receptor antibodies (PLA2R)
Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA)
Anti-histone antibodies (AHA); Anti-intrinsic factor antibodies (IF)
Anti-phospholipase A2 receptor antibodies (PLA2R)
Anti-liver cytosol antibodies (LC-1); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-soluble liver antigen/liver-pancreas antibodies (SLA/LP)
Anti-β2-glycoprotein-I antibodies
Anti-cardiolipin antibodies (ACA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-thyroid peroxidase antibodies (TPO)
Anti-liver cytosol antibodies (LC-1); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-myositis antibodies; Anti-soluble liver antigen/liver-pancreas antibodies (SLA/LP)
Anti-thyrotropin receptor antibodies (TSHR)
Anti-RNA polymerase III antibodies (ARA, RNAP)
Serum Anti-glutamic acid decarboxylase antibodies (GAD); Anti-islet cell antigen 2 antibodies
Anti-islet cell antibodies (ICA)
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) Serum Api m1 phospholipase A2 - Honey bee; Ara h2 - Peanut; Pol d5 - European paper wasp; Ves v5 - Common wasp; β-Lactoglobulin - Milk
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) Serum Amoxicilloyl group; Ampicilloyl group; Cefaclor; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Protamine; Suxamethonium (succinylcholine)
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) Serum Budgerigar droppings; Budgerigar feathers; Cat dander; Cow dander; Dog dander; Guinea pig epithelium; Horse dander; Mouse urine proteins; Rabbit epithelium; Rat epithelium; Rat urine proteins
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens) Serum Guar gum (E412)
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) Serum Chicken; Egg; Egg white; Egg yolk
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) Serum Blue mussel; Codfish; Crab; Lobster; Oyster; Pacific squid; Salmon; Scallop; Shrimp; Tuna
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) Serum Apple; Apricot; Avocado; Banana; Bromelain (MUXF); Garlic; Kiwi; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Onion; Orange citrus; Peach; Pineapple; Potato; Strawberry; Tomato; Watermelon
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) Serum Beef; Galactose-α-1,3-galactose; Mutton; Pork
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) Serum Casein; Milk
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) Serum Cacao; Chocolate; Omega-5-gliadin; Yeasts
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) Serum Almond; Barley; Brazil nut; Cashew nut; Hazelnut; Lentil; Lupin seed; Macadamia nut; Maize; Oat; Peanut; Pecan nut; Pinenut; Pistachio; Rice; Rye; Sesame seed; Soy bean; Walnut; Wheat
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) Serum Chilli pepper; Mustard
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) Serum Bahia grass; Bermuda grass; Brome grass; Couch grass; Cultivated wheat; Johnson grass; Profilin; Rye grass; Timothy grass; Velvet grass
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) Serum German cockroach; Mosquito
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) Serum Alternaria alternata; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Aspergillus terreus; Cladosporium herbarum; Malassezia spp.; Penicillium chrysogenum (formerly Penicillium notatum); Pityrosporum orbiculare (Malassezia furfur); Setomelanomma rostrata (Helminthosporium halodes); Trichophyton rubrum
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) Serum Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; Glycyphagus domesticus storage mite; Lepidoglyphus destructor storage mite; Tyrophagus putrescentiae storage mite
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) Serum Chlorhexidine; Formaldehyde/formalin; Hexamethylene diisocyanate (1,6-hexamethylene diisocyanate; 1,6-HDI); Latex; α-Amylase
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) Serum Acacia; Australian pine; Eucalyptus; Melaleuca; Olive; Plane tree; Silver birch; Wattle; White pine; Willow salix
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) Serum Bull ant - Myrmecia forficata; Bull ant - Myrmecia nigriceps; Bull ant - Myrmecia pyriformis; Common wasp (yellow jacket) venom; Honey bee venom; Jumper ant; Paper wasp venom
Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) Serum Chenopodium; Goosefoot; Lamb’s quarters; Plantain - English; Russian thistle; Saltwort (prickly); Sheep sorrel; Wall pellitory
Immunopathology - Quantitation of complement proteins Serum Alternative pathway haemolytic complement; Total haemolytic complement
Immunopathology - Quantitative and/or qualitative investigation of proteins Cerebrospinal fluid (CSF) Oligoclonal bands
Faeces Calprotectin
Other body fluids β2-Transferrin
Plasma; Serum Characterisation of paraproteins; Detection and amount of paraproteins
Detection and quantitation of free kappa and free lambda light chains
Characterisation of cryoglobulins; Cryofibrinogen; Cryoglobulins
Serum Protein classes
Urine Detection of Bence Jones proteins
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses Plasma; Serum Total immunoglobulin E
Total immunoglobulin A
Total immunoglobulin G
Immunopathology - Single HLA antigen typing Blood HLA-B27
HLA-B5701
Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation Blood Mycobacterial antigen lymphocyte stimulation
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation Serum Anti-avian IgG - Budgerigar; Anti-avian IgG - Pigeon
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blood Primary immune deficiency disease
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes Blood Primary immune deficiency disease
Molecular genetics - Screening for an unknown mutation - Targeted genes Blood Thiopurine methyltransferase (TPMT) genotyping
Coeliac disease

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes Blood; Bone marrow CSF3R and SETBP1 mutation test; Leukaemic gene rearrangements; Quantitative calculation of p210 positive BCR/ABL1 transcripts

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Chemical pathology - Analysis of calculus Calculi Calcium; Magnesium; Oxalate; Phosphate
Chemical pathology - Detection and/or quantitation of tumour markers Plasma; Serum β2-Microglobulin (B2M)
Serum Chromagranin A
Chemical pathology - Detection and/or quantitation of tumour markers - Testing for the National Bowel Cancer Screening Program Faeces Blood
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) Plasma; Serum Erythropoietin (EPO); Gastrin
Serum Growth hormone; Insulin-like growth factor 1 (IGF-1, somatomedin C)
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia Serum Lipoprotein subclasses
Chemical pathology - Further investigation of renal and/or hepatic function Faeces α1-Antitrypsin
Serum α1-Antitrypsin phenotype
Caeruloplasmin; Haptoglobins; α1-Antitrypsin
Alkaline phosphatase (ALP) isoenzymes; Lactate dehydrogenase (LDH) isoenzymes
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies Blood; Plasma Cholinesterase
Cerebrospinal fluid (CSF) Albumin
Plasma 45 Calcium absorption
Serum Angiotensin converting enzyme (ACE)
Acid phosphatase
Chemical pathology - Investigation of malabsorption - Quantitation of solid tissue enzymes Intestinal tissue Lactase; Maltase; Sucrase
Chemical pathology - Quantitation of precursor and intermediary metabolites Urine Oxalate
Chemical pathology - Quantitation of vitamins Blood Pyridoxine (vitamin B6, pyridoxal, pyridoxamine); Thiamine (vitamin B1)
Serum Ascorbic acid (vitamin C)
25-Hydroxyvitamin D
1,25-Dihydroxyvitamin D
Chemical pathology - Trace element analysis Blood Cadmium; Lead; Magnesium; Manganese; Mercury
Liver Copper
Iron
Plasma; Serum Aluminium; Chromium; Cobalt; Copper; Magnesium; Selenium; Zinc
Urine Arsenic; Cadmium; Chromium; Cobalt; Copper; Iodine; Lead; Magnesium; Manganese; Mercury; Thallium; Zinc
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) Blood Glucose-6-phosphate dehydrogenase (G6PD)
Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses Cerebrospinal fluid (CSF) Total immunoglobulin G

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Microbiology - Bacteriology - Detection of pathogenic bacteria Isolates Legionella pneumophila
Respiratory specimens Legionella pneumophila
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) Eye swabs; Genital swabs; Liquid based cytology specimens; Urine Chlamydia trachomatis; Neisseria gonorrhoeae
Genital swabs; Urine Mycoplasma genitalium
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) Isolates Fungi identification; Yeasts identification
Skin scrapingsNails; Hair Fungi identification; Yeasts identification
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) Bacterial isolates Mycobacterium spp.
Bacterial isolates; Respiratory specimens Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) Genital swabs; Urine Trichomonas vaginalis
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) Liquid based cytology specimens Human papilloma virus (HPV)
Nasal aspirates/washes; Nasopharyngeal and throat swab; Nasopharyngeal swabs Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Nasal aspirates/washes; Nasopharyngeal swabs Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Throat swabs Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Nasal swabs; Nasopharyngeal swabs Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Plasma Human immunodeficiency virus type 1 (HIV-1) RNA
Plasma; Serum Hepatitis B virus (HBV) DNA
Hepatitis C virus (HCV) viral RNA
Microbiology - Molecular biology - Microbial genotyping Plasma Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance
Plasma; Serum Hepatitis C virus (HCV) subtypes
Microbiology - Mycobacteriology - Detection and identification of mycobacteria Blood; Bone marrow Mycobacteria identification
Isolates Mycobacteria identification
Mycobacteria antibiotic susceptibility
Mycobacteria antibiotic susceptibility
Mycobacteria identification
Mycobacteria antibiotic susceptibility
Other body fluids; Respiratory specimens; Tissues Mycobacteria identification
Other body fluids; Respiratory specimens; Tissues; Urine Mycobacteria identification; Other pathogenic bacteria to genus level or species level
Mycobacteria identification
Urine Mycobacteria identification
Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements Blood Fungi identification; Yeasts identification
Cerebrospinal fluid (CSF); Fluids; General swabs; Isolates; Nails; Respiratory specimens; Skin scrapings; Tissues Fungi identification; Yeasts identification
Cerebrospinal fluid (CSF); Fluids; General swabs; Nails; Respiratory specimens; Skin scrapings; Tissues Fungi identification; Yeasts identification
Isolates Fungi identification; Yeasts identification
Yeast susceptibility
Fungi susceptibility; Yeast susceptibility
Fungi identification; Yeasts identification
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation Plasma; Serum Cytomegalovirus antibody (anti-CMV) IgG; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Syphilis Treponema pallidum antibody; Toxoplasma gondii IgG antibody; Toxoplasma gondii IgM antibody

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood Autoimmune polyendocrinopathy syndrome type 1; Factor V Leiden; Factor XIII deficiency; Haemochromatosis; Haemophilia A; Haemophilia B; Haemophilia C; Prothrombin variant; Von Willebrand disorder; α-Thalassaemia; β-Thalassaemia
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes Blood Copy number variation (CNV); Quantitation of donor and recipient bone marrow derived cells in a transplant recipient
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes Formalin fixed paraffin embedded tissue sections Indels; Single nucleotide variants (SNVs)
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Whole exome sequencing for non-inherited (somatic) DNA/RNA changes Blood Fusion genes; Indels; Novel isoforms; Single nucleotide variants (SNVs)
Molecular genetics - Heterozygous loci determinations Blood; Chorionic villus; Products of conception (POC); Tissues Nucleic acid analysis for specific variants
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood Copy number variation (CNV); Indels; Single nucleotide variants (SNVs)
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changes Blood Copy number variation (CNV); Indels; Single nucleotide variants (SNVs)
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood Haemophilia A; Haemophilia B; Haemophilia C
Haemophilia A; Haemophilia B; Haemophilia C; α-Thalassaemia; β-Thalassaemia
Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening) Amniotic fluid; Chorionic villus tissue; Cultured amniotic fluid cells; Cultured chorionic villus cells Haemophilia A; Haemophilia B; α-Thalassaemia; β-Thalassaemia

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood; Bone marrow; Formalin fixed paraffin embedded tissue sections Blood borne tumours; Breast cancer; Solid tumours
Molecular genetics - Heterozygous loci determinations Blood; Tissues Blood borne tumours

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring Serum Itraconazole; Posaconazole; Sulthiame; Voriconazole
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) Serum 17α-Hydroxyprogesterone
Chemical pathology - Investigation of porphyria Blood; Plasma cells Porphyrins - Total
Faeces; Urine Porphyrin isomers; Porphyrins - Total
Urine Porphobilinogen (PBG); δ-Aminolevulinic acid (δ-ALA)
Chemical pathology - Quantitation of vitamins Serum Carotenoids; Retinol (vitamin A); Tocopherol (vitamin E)

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Molecular genetics - DNA sequencing Purified PCR product DNA sequence analysis

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals Urine Ethylglucuronide (ETG); Ethylsulfate

ISO 15189 (2012)

Legal

Medicare expiry date

01 Jan 2024

Last Activity Date

19 Feb 2021

Service Product Determinant
Medico legal drug testing AS/NZS 4308, section 2 Specimen collection, storage, handling and dispatchVarious Collection Centres Urine Colour; Creatinine; Temperature; pH
Medico legal drug testing AS/NZS 4308, section 3 General laboratory requirements Urine General laboratory requirements as described in AS/NZS 4308
Medico legal drug testing AS/NZS 4308, section 4 Laboratory screening procedures Urine Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates
Medico legal drug testing AS/NZS 4308, section 5 Laboratory confirmatory procedures Urine 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Benzylpiperazine (BZP, 1-benzylpiperazine); Buprenorphine; Codeine; Diazepam; Ecgonine methyl ester; Ephedrine; Methadone; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nordiazepam; Oxazepam; Phentermine; Pseudoephedrine (PSE); Temazepam; α-Hydroxyalprazolam
Medico legal drug testing AS/NZS 4760, section 3 General laboratory requirements Oral fluid General laboratory requirements as described in AS/NZS 4760
Medico legal drug testing AS/NZS 4760, section 4 Laboratory screen testing Oral fluid Amphetamine type substances; Cocaine; Cocaine metabolites; Δ-9-Tetrahydrocannabinol (THC-Δ9)
Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures Oral fluid 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Buprenorphine; Clonazepam; Cocaine; Codeine; Diazepam; Ecgonine methyl ester; Flunitrazepam; Lorazepam; Methadone; Methylamphetamine; Midazolam; Morphine; Nitrazepam; Nordiazepam; Oxazepam; Oxycodone; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9)

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.